Renovaro Inc.

Ownership Transactions Reported by 24 Insiders

Symbol
RENB on Nasdaq
Industry
Pharmaceutical Preparations
Location
Century City Medical Plaza, 2080 Century City East, Suite 906 Los Angeles, CA

Insiders trading volume in the past year

Renovaro Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Karen Brink Director, 10%+ Owner $37M Aug 12, 2024
William Anderson Wittekind 10%+ Owner $24M -$726K -2.93% Jul 29, 2024
Serhat Gumrukcu 10%+ Owner $9M May 18, 2022
Rene Sindlev Director, 10%+ Owner $7.21M Jun 25, 2024
Sandler Carl Forest Other* $4.19M Apr 15, 2022
Ole Abildgaard 10%+ Owner $3.66M Aug 22, 2023
Weird Science LLC 10%+ Owner $696K Feb 16, 2018
David Hershel Weinstein Chief Executive Officer, Director $325K Oct 14, 2024
Avram Miller Director $243K Aug 23, 2024
Leni Boeren Director Oct 4, 2023
Henrik Gronfeldt-Sorensen Director Oct 9, 2023
Francois Binette COO and Executive VP for R&D Feb 13, 2024
Mark Dybul Chief Executive Officer, Director Feb 13, 2024
Luisa Puche Chief Financial Officer Feb 13, 2024
Maurice van Tilburg Director Oct 14, 2024
James Sapirstein Director Jun 25, 2024
Douglas Calder Director Nov 4, 2024
Simon Tarsh Interim CFO Nov 4, 2024
Carol L. Brosgart Director Jun 25, 2024
Mark Collins Director Nov 4, 2024
James Mcnulty Director Nov 4, 2024
Jayne McNicol Director Jun 25, 2024
Ruud Hendriks Director Jun 25, 2024
Gregg H. Alton Director Jun 25, 2024

Recent Insider Transactions by Companies or Individuals for Renovaro Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.